Fig. 4From: The emerging role of MicroRNA-182 in tumorigenesis; a promising therapeutic targetThe schematic view of miR-182 involvement in β-catenin signaling through pancreatic tumorigenesis. β-TrCP, which induces the proteasome-mediated degradation of β-catenin, is inhibited by miR-182, promoting cell proliferation by β-catenin-mediated upregulation of C-myc and Cyclin D1Back to article page